Abolfathzadeh, N. and Naseripour, M. and Jaberi, R. and Azma, Z. and Alemzadeh, S.A. and Arbab, M. and Sedaghat, A. (2020) Ru-106 plaque radiotherapy for vasoproliferative tumors of retina: a 15-year single-center experience. International Ophthalmology, 40 (8). pp. 2095-2102.
Full text not available from this repository.Abstract
Purpose: This study evaluates the outcomes of ruthenium-106 (Ru-106) plaque brachytherapy for vasoproliferative tumors (VPTs) of the ocular fundus in a single referral ocular oncology center. Methods: The clinical charts of all patients diagnosed with VPT who underwent plaque radiotherapy from 2002 to 2017 were reviewed. Clinical features, types of treatment, outcomes and complications were evaluated. Results: Of 46 patients with VPT diagnosis in our ocular oncology clinic, 25 (54.34) cases were treated with Ru-106 plaque brachytherapy. Eleven patients (44) were male, and the mean age at the time of diagnosis was 40.92 ± 13.11 years. The mean follow-up time was 47.56 ± 36.87 months. Inferotemporal quadrant was the most common site of the tumor (64.00). The mean delivered apex and scleral dose was 101.56 ± 6.51 and 412.26 ± 113.66 Gray (Gy), respectively. Initial tumor length, width and thickness were 10.26 ± 3.42, 8.05 ± 2.83 and 4.27 ± 1.10 mm, respectively. The mean tumor thickness decreased to 2.60 ± 0.63 mm, postoperatively. Complete resolution of subretinal fluid around the tumor was achieved in 81.80 of cases. Visual acuity was more than 20/400 in 64 of patients before treatment and 60 of patients at last follow-up. Conclusion: Our study showed that Ru-106 plaque radiotherapy is an effective and safe method of treatment in VPTs. © 2020, Springer Nature B.V.
Item Type: | Article |
---|---|
Additional Information: | cited By 0 |
Uncontrolled Keywords: | ruthenium 106, adolescent; adult; Article; cancer radiotherapy; clinical article; clinical effectiveness; clinical evaluation; clinical feature; controlled study; eye fundus; female; follow up; human; male; medical record review; plaque radiotherapy; postoperative period; radiation dose; retina tumor; retrospective study; safety; sclera; treatment outcome; tumor localization; tumor volume; vasoproliferative tumor; visual acuity |
Subjects: | WW Ophthalmology |
Depositing User: | eprints admin |
Date Deposited: | 28 Sep 2020 07:15 |
Last Modified: | 28 Sep 2020 07:15 |
URI: | http://eprints.iums.ac.ir/id/eprint/23184 |
Actions (login required)
![]() |
View Item |